Search - tctmd.com

Displaying 241 - 260 of 649

Sort: Relevancy | Date

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

Todd Neale

November 06, 2022

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Todd Neale

November 05, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

News Conference News HFSA 2022

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

L.A. McKeown

October 07, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

GDMT With ARNI Lessens MR, Perhaps Obviating Need for Interventions

News Conference News HFSA 2022

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Michael O'Riordan

October 04, 2022

News Daily News

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

Michael O'Riordan

October 03, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events

Michael O'Riordan

September 26, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Daily News

Obesity May Boost Thrombotic Events in Contraceptive Users, Review Suggests

L.A. McKeown

September 16, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Daily News

Older Adults See Rebound in Rates of HF-Related Death: CDC Data

Caitlin E. Cox

September 09, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Caitlin E. Cox

August 31, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Shelley Wood

August 27, 2022

Advertisement

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

November 2022 News Roundup

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

REDWOOD-HCM OLE: Aficamten Improves Patient-Measured Health Status

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions

Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues

October 2022 News Roundup

mRNA Vaccine-Linked Myocarditis Resolves in Time, Without Clinical Events

Most Patient-Reported Outcome Measures in CVD Fall Short

Obesity May Boost Thrombotic Events in Contraceptive Users, Review Suggests

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Older Adults See Rebound in Rates of HF-Related Death: CDC Data

CV Care Around Noncardiac Surgery: New ESC Guidelines

New Faces, New Formats, New Tech: What to Expect From TCT 2022

New on the Scene Nonstatin Drugs: Experts Provide Guidance

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content